Impairments in the insulin signaling pathway leads to insulin resistance, defined as reduced responsiveness of target tissues to circulating levels of insulin [3,4,5], and type 2 diabetes mellitus (T2DM) [1,3,4]. This evidence concerns the gene INS and diabetes mellitus.